000 01130 a2200301 4500
005 20250516194330.0
264 0 _c20140211
008 201402s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc1315234
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuintas-Cardama, Alfonso
245 0 0 _aPonatinib in Philadelphia chromosome-positive leukemias.
_h[electronic resource]
260 _bThe New England journal of medicine
_c02 2014
300 _a577 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aPyridazines
_xtherapeutic use
650 0 4 _aThrombosis
_xchemically induced
773 0 _tThe New England journal of medicine
_gvol. 370
_gno. 6
_gp. 577
856 4 0 _uhttps://doi.org/10.1056/NEJMc1315234
_zAvailable from publisher's website
999 _c23518818
_d23518818